Skip to Main Content

David Liu

Director of the Merkin Institute for Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard

In July 2021 Liu raised $315 million to launch Prime Medicine, which aims to use prime editing, a DNA-rewriting method developed in his Broad Institute lab, to treat rare genetic diseases. It’s the sixth startup co-founded by Liu, who has invented multiple tools for precision genetic medicine. Another, Beam Therapeutics, advanced several research programs last year using base editing (a way to reverse the single-point DNA mutations behind many diseases) to help patients with sickle cell disease produce normal hemoglobin.

From STAT:



  • 48


  • Cambridge, MA


The definitive list of authoritative leaders and influencers in health and life science

View the List